Arrow Alexander K. Insider Trades

Insider Trading History

Track insider trading activity for Arrow Alexander K.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Chief Financial Officer
Holding Value $53k 100,000 shares
Last Trade
Mar 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.44M 100,000 shares
$24.36
$0.53
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Chief Financial Officer
Holding Value $1.5k 100,000 shares
Last Trade
Mar 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.71k 100,000 shares
$0.03
$0.02
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Chief Financial Officer
Holding Value $687 45,815 shares
Last Trade
Oct 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$224 8,000 shares
$0.03
$0.02
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Chief Financial Officer
Holding Value $24.3k 45,815 shares
Last Trade
Oct 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$82.8k 8,000 shares
$10.35
$0.53
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Chief Financial Officer
Holding Value $2.27k 151,260 shares
Last Trade
May 17, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.1k 31,000 shares
$0.10
$0.02
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Chief Financial Officer
Holding Value $80.2k 151,260 shares
Last Trade
May 17, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$320k 8,000 shares
$40.04
$0.53
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Chief Financial Officer
Holding Value $26.5k 50,000 shares
Last Trade
Jun 03, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.46M 16,900 shares
$145.60
$0.53
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Chief Financial Officer
Holding Value $750 50,000 shares
Last Trade
Jun 03, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.44k 16,900 shares
$0.44
$0.02
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Chief Financial Officer
Holding Value $17.5k 33,100 shares
Last Trade
Jun 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.9k 100 shares
$128.80
$0.53
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Chief Financial Officer
Holding Value $497 33,100 shares
Last Trade
Jun 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38.6 100 shares
$0.39
$0.02
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Chief Financial Officer
Holding Value $17.5k 33,000 shares
Last Trade
May 27, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$407k 3,000 shares
$135.52
$0.53
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Chief Financial Officer
Holding Value $495 33,000 shares
Last Trade
May 27, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.27k 3,000 shares
$0.42
$0.02
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Chief Financial Officer
Holding Value $15.9k 30,000 shares
Last Trade
May 18, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.61M 30,000 shares
$120.40
$0.53
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Chief Financial Officer
Holding Value $450 30,000 shares
Last Trade
May 18, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.1k 30,000 shares
$0.34
$0.02
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Chief Financial Officer
Holding Value $1.8k 120,260 shares
Last Trade
Apr 30, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$375 1,000 shares
$0.38
$0.02
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Chief Financial Officer
Holding Value $63.7k 120,260 shares
Last Trade
Apr 30, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$127k 1,000 shares
$126.56
$0.53
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Chief Financial Officer
Holding Value $63.2k 119,260 shares
Last Trade
Apr 29, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$132k 1,000 shares
$132.16
$0.53
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Chief Financial Officer
Holding Value $1.79k 119,260 shares
Last Trade
Apr 29, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$350 1,000 shares
$0.35
$0.02
Protagenic Therapeutics
Protagenic Therapeutics PTIX
Chief Financial Officer
Holding Value $66.2k 124,998 shares
Last Trade
Jul 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.53
Protagenic Therapeutics- Warrants (13/04/2025)
Protagenic Therapeutics- Warrants (13/04/2025) PTIXW
Chief Financial Officer
Holding Value $1.87k 124,998 shares
Last Trade
Jul 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up